The Column
It's the chemical industry, distilled.
Connect
Better caustic soda, making use of lithium in the Smackover, and trying to commercialize cleaner iron.
Solugen's new funding, Ambercycle's latest deal, petrochemical problems in Australia.
Trillium's bio-based acrylonitrile, Covestro's investment in BioBTX, and Oxy's DLE deal.
Fulcrum Bioenergy’s demise, DuPont is splitting into pieces, and a standalone ethylene-to-alky unit.
A new PO process, recycling PVC, making CO2 free cement, and converting naphtha into ethane and propane.
A bio-based 1,3 propanediol expansion, less BASF in Ludwigshafen, Equinor bought into Standard Lithium, Ashland is selling its nutraceutical biz.
Origin's cap business, SK Geocentric’s better PLA process, Ex-Solvay and Orbia broke ground, and Potassium formate from CO2.
Encina isn’t going to Pennsylvania, Anellotech and Technip signed a deal, Standard Lithium started up its demo-scale DLE plant, and SK Capital sold Foremark after 7 years.
Guess who's back?
Ineos' EO acquisition, Lanxess and sulfur carriers, sustainable EO, CO2 to methanol, and Cyclyx's first plant.
Clariant's cellulosic bioethanol, reducing CO2 to CO, financing lithium, retrofitting a refinery, electrolytes, sodium sulfate, and licensing.
